Overview
PER’s 11th Annual School of Gastrointestinal Oncology® (SOGO®) is a 1-day multidisciplinary educational conference, featuring discussions of emerging therapies and evolving standards of care for patients with gastrointestinal (GI) cancer.
This symposium, now in its eleventh year, is focused on providing tools to personalize care for patients with GI cancer. The program will feature discussion of hot topics of debate across all GI malignancies, as well as discussions on multidisciplinary, real-world management of GI cancers. This program is designed to match your learning interests, with updates on the latest clinical trial data, current and emerging treatment strategies, and case-based lectures by expert faculty with a focus on the practical application of knowledge to the complex care scenarios encountered in contemporary practice settings. Physicians’ Education Resource® (PER®) is committed to deliver an interactive meeting that fosters discussion, exchange of ideas, best practices, and multidisciplinary collaboration in the clinic.
Learning Objectives
Upon completion of this activity, learners will be better able to:
- Assess the clinical utility of novel molecular and genomic strategies for personalizing treatment decisions in patients with gastrointestinal (GI) cancers
- Evaluate the clinical impact of recent findings from landmark trials of emerging treatment strategies for the management of GI cancers
- Apply evolving evidence into individualized, multidisciplinary care strategies to improve outcomes for patients with GI cancers
- Implement best practices for preventing, recognizing, and managing TRAEs associated with novel therapies used for the management of GI cancers
Program Co-Chairs
E. Gabriela Chiorean, MD; Anthony El-Khoueiry, MD
To view full profile, click on the Program Co-Chairs tab above.

E. Gabriela Chiorean, MD
Professor of Medicine, University
of Washington School of Medicine
Clinical Director, Gastrointestinal Oncology
Professor, Fred Hutchinson Cancer
Center
Seattle, WA

Anthony El-Khoueiry, MD
Associate Director for Clinical Research
Chief, Section of Developmental Therapeutics/Phase I Program
Verna R. Richter Chair in Cancer Research
USC Norris Comprehensive Cancer Center
Los Angeles, CA
Click the button below to view all faculty presenters.
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 5.25 Contact Hours.
Medical Oncologists (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
(Please note: The credit amounts above include credit for the main session presentations as well as the featured symposium.)

Show Me the Data®: From Mutation to Action — KRAS as a Therapeutic Target in PDAC
Date: Saturday, April 11, 2026
Location: Join virtually or in person in Los Angeles, CA
Venue: Sheraton Grand Los Angeles
Scientific Session: 11:15 AM - 11:45 AM PT








